Publications by authors named "G Scarpelli"
Background: The issue of retreatment with surfactant of infants with respiratory distress syndrome (RDS) has been poorly investigated. Our aim was to identify possible clinical predictors of the need for multiple doses of surfactant in a large cohort of very preterm infants.
Methods: Data were analyzed from three previous studies on infants born between 25 and 31 weeks of gestation with RDS who were treated with surfactant.
Importance: A multicenter randomized clinical trial (RCT) showed a lung recruitment maneuver using high-frequency oscillatory ventilation just before surfactant administration (ie, intubate-recruit-surfactant-extubate [IN-REC-SUR-E]) improved the efficacy of treatment compared with the standard intubate-surfactant-extubate (IN-SUR-E) technique without increasing the risk of adverse neonatal outcomes.
Objective: To examine follow-up outcomes at corrected postnatal age (cPNA) 2 years of preterm infants previously enrolled in an RCT and treated with IN-REC-SUR-E or IN-SUR-E in 35 tertiary neonatal intensive care units.
Design, Setting, And Participants: This was a follow-up study of infants recruited into the primary RCT from 2015 to 2018 at 35 tertiary neonatal intensive care units (NICUs) in Italy.
The aim of "Precision Surgery" is to reduce the impact of surgeries on patients' global health. In this context, over the last years, the use of three-dimensional virtual models (3DVMs) of organs has allowed for intraoperative guidance, showing hidden anatomical targets, thus limiting healthy-tissue dissections and subsequent damage during an operation. In order to provide an automatic 3DVM overlapping in the surgical field, we developed and tested a new software, called "ikidney", based on convolutional neural networks (CNNs).
View Article and Find Full Text PDFArticle Synopsis
- Half of very preterm infants with respiratory distress syndrome fail treatment with nasal continuous positive airway pressure (NCPAP) and need mechanical ventilation (MV).
- This study aimed to compare nasal intermittent positive pressure ventilation (NIPPV) and NCPAP during less invasive surfactant treatment (LISA) for improving respiratory outcomes.
- Results showed no significant difference in respiratory outcomes between NIPPV and NCPAP, suggesting that both methods are equally effective and safe during LISA.
Article Synopsis
- Recessive dystrophic epidermolysis bullosa (RDEB) is a rare skin disorder caused by mutations in the COL7A1 gene, leading to persistent blistering and fibrosis without a cure.
- The study focuses on the NOTCH signaling pathway, which is implicated in the fibrosis associated with RDEB, and examines the effects of γ-secretase inhibitors, specifically DAPT and PF-03084014 (nirogacestat), on RDEB fibroblasts.
- Results show that inhibiting NOTCH signaling with PF-03084014 reduces fibrotic traits such as contractility and collagen secretion in RDEB fibroblasts, offering potential new therapeutic strategies for managing RDEB-associated fibrosis.